___

• 1. Işçi Bostanci E, Durmuş Y, Duru Çöteli SA, Kayikçioğlu F, Boran N. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/ endometrial cancer: Wait or treat! Turkish Journal Of Medical Sciences 2021; 51 (4):2066-2072. doi: 10.3906/sag-2012-207
• 2. Cordeiro Mitchell CN, Hunkler KF, Maher JY, Garbose RA, Gornet ME et al. Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae. Journal of Gynecology Obstetrics and Human Reproduction 2021; 50 (5):101930. doi: 10.1016/j.jogoh.2020.101930
• 3. Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL et al. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/ endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates. Gynecologic Oncology 2020; 157 (2):348-356. doi: 10.1016/j. ygyno.2020.02.008
• 4. Raffone A, Travaglino A, Saccone G, Di Maio A, Mollo A et al. Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecological Endocrinology 2019; 35 (11):932- 937. doi: 10.1080/09513590.2019.1624716